Wyatt Technology Unveils New Brochure for its Newly Launched DynaPro NanoStar Protein Analysis Tool
News Mar 23, 2009
The comprehensive, eight-page document outlines the NanoStar’s wide range of applications, including screening proteins prior to crystallization trials, bioprocessing and quality control of viral particles and vaccines, exploring antibody formulations, characterizing stable protein formulations and aggregating compounds. The brochure describes how the NanoStar surpasses the performance of conventional batch DLS instruments, delivering optimum versatility and stability with more than twice the signal-to-noise of its predecessors to ensure consistently high performance.
Wyatt’s informative collateral details how the new NanoStar works, explaining how simple it is to install on a laboratory network and operate from anywhere with an Internet connection. In addition, the brochure provides a thorough insight into the many benefits of the novel instrument resulting from its multi-mode optical fiber, auto-attenuation and rapid thermal characterization capabilities.
Built on breakthrough technology, the NanoStar incorporates two light scattering detectors in its optical system, offering the unique advantage of measuring hydrodynamic radii and absolute molecular weights simultaneously. The instrument can be also attached to Wyatt’s DAWN® HELEOS™ or miniDAWN™ TREOS™ multi-angle light scattering (MALS) systems for simultaneous on-line MALS and DLS characterization.
Incorporated in the document are real world data from a thermal melt experiment performed by NanoStar on 0.96 mg/ml BSA in PBS, automatically ramping from 30°C to 80°C at a programmed ramp rate of 0.25°C/min. Results of the experiment are demonstrated using screenshots generated by the DYNAMICS™ software platform on which the NanoStar operates. The brochure also refers to Wyatt’s patented DynaPro Plate Reader, designed to automate and accelerate DLS measurements. It concludes by drawing a comparison between the specifications of the two instruments, helping readers to identify the most suitable one for their specific application needs.
XenoGesis and BioAscent Forge Alliance to Offer Enhanced Integrated Drug Discovery ServicesNews
XenoGesis and BioAscent Discovery Limited have announced a collaboration to offer an enhanced range of integrated drug discovery services, including medicinal chemistry, biology and DMPK.READ MORE
BioAscent Establishes Integrated Drug Discovery Services OfferingNews
Dr Phil Jones to join as new CSO to lead company’s extended capabilities in medicinal chemistry and in vitro biosciences.READ MORE
Lab Innovations returns to the NEC, Bimingham , UKNews
Save the date for the UK’s only lab-dedicated exhibition showcase!READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018